Brief: Vericel Q2 EPS USD -0.1
01/08/2024 12:55
Aug 01 (Reuters) - Vericel Q2 adjusted EBITDA USD 6.3 million vs. IBES estimate USD 7.07 million. * Q2 adjusted EBITDA margin 12% * Q2 gross margin 70% * Q2 net income USD -4.7 million * outlook FY revenue USD 238-242 million
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook